Stock Analyst Rating Reiterations → Warning: this could blow your mind (From DTI) (Ad) Reporting Date Country USA (NYSE & NASDAQ) United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action All Ratings Strong Buy Buy Hold Sell Rating Export to Excel CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsAAPLApple Reiterated byDZ BankSubscribe to MarketBeat All Access for the recommendation accuracy rating$173.31+2.1% $180.00Buy ➝ HoldAINAlbany International Reiterated byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$96.40+1.9%$105.00 ➝ $95.00Neutral ➝ UnderperformAQMSAqua Metals Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$0.52-1.9% $4.00Buy ➝ BuyAZTAAzenta Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$59.43+1.8% $75.00Buy ➝ BuyBACBank of America Reiterated byHSBCSubscribe to MarketBeat All Access for the recommendation accuracy rating$37.83+2.0%$38.00 ➝ $39.00Buy ➝ HoldBRZEBraze Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$50.58+2.3% $66.00Overweight ➝ Overweight Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BRZEBraze Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$50.58+2.3% $70.00Buy ➝ BuyBRZEBraze Reiterated byOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy rating$50.58+2.3% $75.00Outperform ➝ OutperformBRZEBraze Reiterated byWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy rating$50.58+2.3%OutperformCARACara Therapeutics Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$0.87+19.2% $5.00Buy ➝ BuyCELCCelcuity Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingS. RamakanthSubscribe to MarketBeat All Access for the recommendation accuracy rating$18.16+3.7% $27.00Buy ➝ BuyCLRBCellectar Biosciences Reiterated byOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy rating$3.64-5.7%$11.00 ➝ $12.00Outperform ➝ OutperformCXMSprinklr Reiterated byWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy rating$13.00+1.4%OutperformCXMSprinklr Reiterated byOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy rating$13.00+1.4%Market Perform ➝ Market PerformDRRXDURECT Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingE. ArceSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.34+5.5%NeutralEFTReFFECTOR Therapeutics Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$13.45+4.2% $24.00Buy ➝ BuyERASErasca Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingA. MaldonadoSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.06+4.0% $8.00Buy ➝ BuyEXRExtra Space Storage Reiterated byRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy rating$146.75+4.5% $160.00Strong-Buy ➝ OutperformFNAParagon 28 Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$11.92+16.3% $17.00Buy ➝ BuyGLPGGalapagos Reiterated byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$32.95+0.7%$41.00 ➝ $31.00Neutral ➝ UnderperformMMacy's Reiterated byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$19.85+4.0% $21.00Market Perform ➝ Market PerformMGXMetagenomi Reiterated byChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy rating$11.09-2.0%$21.00 ➝ $21.00Buy ➝ BuyMRNAModerna Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$110.59+3.0%HoldPARPAR Technology Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$45.08+5.5% $53.00Buy ➝ BuyPEBPebblebrook Hotel Trust Reiterated byCompass PointSubscribe to MarketBeat All Access for the recommendation accuracy rating$15.58+1.6% $17.00Buy ➝ NeutralREEREE Automotive Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingA. DayalSubscribe to MarketBeat All Access for the recommendation accuracy rating$5.84-7.0% $15.00Buy ➝ BuyRUMRumble Reiterated byOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy rating$8.50-1.3%Market Perform ➝ Market PerformSLDBSolid Biosciences Reiterated byWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy rating$14.25+5.0%OutperformSLESuper League Enterprise Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.50+9.2% $3.00Buy ➝ BuySPXCSPX Technologies Reiterated byOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy rating$121.42+0.6%$124.00 ➝ $134.00Outperform ➝ OutperformTRNOTerreno Realty Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$65.34+2.3% $67.00Neutral ➝ NeutralVISTVista Energy Reiterated byUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$42.24+0.6%$40.00 ➝ $47.00Buy ➝ NeutralVRNTVerint Systems Reiterated byOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy rating$31.09+0.5%Market Perform ➝ Market PerformVRNTVerint Systems Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$31.09+0.5% $40.00Buy ➝ BuyWBWeibo Reiterated byThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$9.50+4.1% $10.60Buy ➝ NeutralAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 09:10 AM ET. Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage. Email Address Stock Ratings Reports and Tools Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Company Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Ratings for Popular Stocks: Alphabet (Google) Amazon Apple Meta (Facebook) Microsoft Netflix Nvidia Tesla Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.